6 Major subsidiaries
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31.12.2022 |
|
31.12.2021 |
||
|
|
|
|
|
|
|
|
|
|
|
Share of |
|
Share of |
||
|
Company name |
|
Domicile |
|
Purpose |
|
Currency |
|
Share capital/Nominal capital |
|
Capital |
Voting rights |
|
Capital |
Voting rights |
|
Fully consolidated companies |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bellevue Group AG |
|
Küsnacht, Switzerland |
|
Holding |
|
CHF |
|
1 346 143 |
|
Parent company |
|
Parent company |
||
|
Bellevue Asset Management AG |
|
Küsnacht, Switzerland |
|
Asset Management |
|
CHF |
|
1 750 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Asset Management (Deutschland) GmbH (previously: StarCapital AG) 1) |
|
Frankfurt am Main, Germany |
|
Asset Management |
|
EUR |
|
540 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Asset Management (UK) Limited |
|
London, UK |
|
Asset Management |
|
GBP |
|
50 000 |
|
100% |
100% |
|
100% |
100% |
|
Asset Management BaB N.V. |
|
Curaçao |
|
Asset Management |
|
USD |
|
6 001 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Research Inc. |
|
New York, USA |
|
Research |
|
USD |
|
100 |
|
100% |
100% |
|
100% |
100% |
|
BB Biotech Ventures GP |
|
Guernsey |
|
Investment Advisor |
|
GBP |
|
10 000 |
|
100% |
100% |
|
100% |
100% |
|
BB Pureos Bioventures GP Limited |
|
Guernsey |
|
Investment Advisor |
|
GBP |
|
60 000 |
|
99% |
99% |
|
99% |
99% |
|
Bellevue Private Markets AG |
|
Zug, Switzerland |
|
Investment Advisor |
|
CHF |
|
1 000 000 |
|
100% |
100% |
|
100% |
100% |
|
adbodmer AG |
|
Zug, Switzerland |
|
Investment Advisor |
|
CHF |
|
100 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Komplementär AG |
|
Küsnacht, Switzerland |
|
Asset Management |
|
CHF |
|
200 000 |
|
100% |
100% |
|
100% |
100% |
|
Bellevue Private Markets Management I S.à.r.l. 2) |
|
Luxembourg |
|
Asset Management |
|
EUR |
|
12 000 |
|
100% |
100% |
|
0% |
0% |
|
Bellevue Asset Management (Deutschland) GmbH (old) 1) |
|
Frankfurt am Main, Germany |
|
Asset Management |
|
EUR |
|
25 000 |
|
0% |
0% |
|
100% |
100% |
|
Realwerk AG 3) |
|
Zug, Switzerland |
|
Investment Advisor |
|
CHF |
|
100 000 |
|
0% |
0% |
|
100% |
100% |
1) Bellevue Asset Management (Deutschland) GmbH was absorbed by StarCapital AG as of July 1, 2022. StarCapital AG was subsequently renamed Bellevue Asset Management (Deutschland) GmbH as part of change in legal form.
2) The Company was founded on August 30, 2022.
3) Realwerk was merged with Bellevue Private Markets Ltd as of January 1, 2022.
Minority shareholders’ equity ownership of BB Pureos Bioventures GP Limited is 1%. Due to the non-materiality of this ownership with respect to the overall Bellevue Group’s equity and comprehensive income, no separate disclosure of minority shareholders has been published on the Group’s financial statements.